Safdar A*, Decker WK, Li S, Shpall EJ, Bollard CM. T-lymphocyte response against baculovirus-derived recombinant influenzavirus hemagglutinin generated by an umbilical cordblood model of dendritic cell vaccination. Abstract # 3905. The 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America 46thAnnual Meeting, October 25–28, 2008, Washington, DC

/in /by

Georgescu G, Rodriguez GE, Champlin RE, & Safdar A. Effect of granulocyte macrophage-colony stimulating factor in invasive fungal infections following stem cell transplantation. Abstract # 3571. The 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America46thAnnual Meeting, October 25–28, 2008, Washington, DC

/in /by

Rodriguez G. Georgescu G, Islam S, & Safdar A. Safety of granulocyte macrophage-colony stimulating factor in 66 cancer patients with invasive fungal infections. Abstract # 3520. The 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America46thAnnual Meeting, October 25–28, 2008, Washington, DC

/in /by

Rodriguez G, Mora L, Khouri I, Champlin R, & Safdar A. Infectious complication in non-Hodgkin’s lymphoma and chronic lymphocytic leukemia following non-myeloablative stem cell transplantation: a review of homogenous population during 1999–2004. Abstract # 4675. The 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America 46thAnnual Meeting, October 25–28, 2008, Washington, DC

/in /by

Safdar A*. Vaccination in patients with cancer: strategies to prevent influenza and pneumococcal Disease. The 2nd World Conference on Magic Bullets (Ehrlich II), International Society of Chemotherapy. October 3-5, 2008, Nürnberg, Germany ORAL PRESENTATION

/in /by

Safdar A*, Decker WK, Li S, Shpall EJ. De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cordblood model of dendritic cell vaccination. Abstract # 36. The 15th Symposium on Infections in the Immunocompromised Host. The International Immunocompromised Host Society. June 22–25, 2008, Thessaloniki, Greece.

/in /by

Safdar A*, Decker W, Shpall E. Generation of influenza recombinant hemagglutinin-specific lymphocytes from cordblood-derived dendritic cells: immunotherapy model from an unprimed source. Abstract # P765. The 18th European Congress of Clinical Microbiology and Infectious Diseases. April 19–22, 2008, Barcelona, Spain.

/in /by

Rodriguez G, Safdar A, Bodey G, Rolston K. Polymicrobial bacteremia in cancer patients. The 18th European Congress of Clinical Microbiology and Infectious Diseases. April 19 to April 22, 2008, Barcelona, Spain.

/in /by

Saliba RM, Couriel D, Komanduri K, Patch PA, Westin J, Giralt S, Cooper L, Petropoulous D, Worth L, Safdar A, Champlin RE, Shpall EJ, de Lima M. Incidence and risk factors for chronic graft-versus-host disease after cord blood transplantation. Abstract # 362. BMT tandem meetings organized by the American Society of Bone Marrow Transplantation and the Center for International Bone marrow Transplantation Research. 2008 Biology of Blood and Marrow Transplantation – BIOL BLOOD MARROW TRANSPLANT 01/2008; 14(2):132-133. DOI:10.1016/j.bbmt.2007.12.372

/in /by

Safdar A*, Rodriguez GH, Rueda-Jaimes AM, Wierda WG, Ferrajoli A, O’Brien S, Koller CA, Musher DM, Bodey GP, Keating MJ. Immunogenicity and safety of multi-dose granulocyte macrophage-colony stimulating factor immune enhancement in patients with chronic lymphocytic leukemia receiving 23-valent polysaccharide pneumococcal vaccine: a prospective, randomized, controlled trial. Abstract # M-1006. The 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. September 17–20, 2007, Chicago.

/in /by